Menthol Enhances an Antiproliferative Activity 
of 1α,25-Dihydroxyvitamin D3 in LNCaP Cells by Park, Eun-Jung et al.
125
Original Article J. Clin. Biochem. Nutr., 44, 125–130, March 2009
JCBN Journal of Clinical Biochemistry and Nutrition 0912-0009 1880-5086 the Society for Free Radical Research Japan Kyoto, Japan jcbn08-201 10.3164/jcbn.08-201 Original Article Menthol Enhances an Antiproliferative Activity 
of 1α,25-Dihydroxyvitamin D3 in LNCaP Cells
Eun-Jung Park, Su-Hwa Kim, Byung-Joo Kim, Sung-Young Kim, Insuk So, and Ju-Hong Jeon*
Department of Physiology, Seoul National University College of Medicine, Seoul 110-799, Korea
3 2009 ?? 2 2009 44 2 125 130 Received 24.7.2008 ; accepted 8.9.2008
*To whom correspondence should be addressed. 
Tel: +82-2-740-8399    Fax: +82-2-763-9667    
E-mail: jhjeon2@snu.ac.kr
Received 24 July, 2008; Accepted 8 September, 2008
Copyright © 2009 JCBN Summary 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3], the most active form of vitamin D3,
and its analogues have therapeutic benefits for prostate cancer treatment. However, the
development of hypercalcemia is an obstacle to clinical applications of 1α,25(OH)2D3 for cancer
therapy. In this study, we provide evidence that menthol, a key component of peppermint oil,
increases an anti-proliferation activity of 1α,25(OH)2D3 in LNCaP prostate cancer cells. We
found that menthol per se does not exhibit antiproliferative activity, but it is able to enhance
1α,25(OH)2D3-mediated growth inhibition in LNCaP cells. Fluorometric assays using Fura-2
showed that 1α,25(OH)2D3 does not induce acute Ca2+ response, whereas menthol evokes an
increase in [Ca2+]i, which suggests that cross-talks of menthol-induced Ca2+ signaling with
1α,25(OH)2D3-mediated growth inhibition pathways. In addition, Western blot analysis
revealed that 1α,25(OH)2D3 and menthol cooperatively modulate the expression of bcl-2 and
p21 which provides the insight into the molecular mechanisms underlying the enhanced
1α,25(OH)2D3-mediated growth inhibition by menthol. Thus, our findings suggest that menthol
may be a useful natural compound to enhance therapeutic effects of 1α,25(OH)2D3.
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Introduction
Prostate cancer, the most commonly diagnosed non-
cutaneous cancer, is one of the main causes of cancer death
in men [1]. It is a heterogeneous disease with a highly varied
clinical course ranging from asymptomatic to fatal malig-
nancy [2]. Initial growth of prostate cancer depends on
androgen, and thereby responds to androgen-deprivation
therapy [2]. However, almost all of the patients eventually
become refractory to androgen-deprivation therapy and die
of recurrent androgen-independent cancer for which no
effective therapy is available [2].
Many epidemiologic studies have identified the low level
of circulating 25-hydroxyvitamin D3, the most commonly
used index of vitamin D status, as a significant risk factor
for prostate cancer [3]. Recent clinical trials have proven
that 1α, 25-dihydroxyvitamin D3 [1α,25(OH)2D3] and its
analogues have therapeutic benefits for cancer treatment [4,
5]. 1α,25(OH)2D3 exerts antitumor effects through the tran-
scriptional regulation of the genes involved in cell cycle,
differentiation, and apoptosis [6]. 1α,25(OH)2D3-mediated
transcription is achieved by its binding to vitamin D receptor
(VDR), of which knockout mice are vulnerable to chemical
carcinogenesis in several tissues [5,  7]. In addition,
1α,25(OH)2D3 can elicit transcription-independent non-
genomic responses, such as acute Ca2+ influx and its
resultant signaling cascade activation, which can in turn
elevate VDR activity [4,  8]. Thus, an understanding of
vitamin D signaling pathways can help to devise novel
approaches to prostate cancer therapy. However, administra-
tion of 1α,25(OH)2D3 is limited by hypercalemic toxicity
[4, 5]. Thus, the development of safe and effective strategies
improving anticancer efficacy and reducing toxicity is
required for successful use of 1α,25(OH)2D3.
Menthol, 2-isopropyl-5-methylcyclohexanol, has beenE.-J. Park et al.
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widely used as an active ingredient of food, cosmetical, and
pharmaceutical products [9]. It is a key component of
peppermint oil that has a variety of biological activities,
including antitumor activity and chemopreventive potential
[10]. Because menthol was found to increase [Ca2+]i in
prostate cancer cell lines [11, 12], we questioned whether
menthol can enhance an antiproliferative activity of
1α,25(OH)2D3. In this study, we demonstrated that menthol
per se little affects cell growth but enhances an anti-
proliferative activity of 1α,25(OH)2D3 in LNCaP prostate
cancer cells. Our findings suggest that a combination of
1α,25(OH)2D3 with menthol could be a promising thera-
peutic strategy for prostate cancer.
Materials and Methods
Cell culture
LNCaP cells were supplied by Korean Cell Line Bank
(KCLB, Seoul, Korea) and maintained in RPMI media plus
10% FBS. All cell culture agents used were obtained from
Invitrogen. 1α,25(OH)2D3 and (−)-menthol (Sigma, St.
Louis, MO) in ethanol were added to the culture medium as
the indicated concentrations or times.
Cell growth assay
LNCaP cells were grown in 12-well or 24-well culture
plates (Nunc, Roskilde, Denmark). MTT assay was used to
assess cell growth according to the manufacturer’s instruc-
tion (Sigma). Assays were quantitated by measuring the
absorbance at 570 nm on a microplate spectrophotometer
(Asys Hitech, Cambridge, UK).
Intracellular Ca2+ measurement
The detached cells were incubated with 5 μM Fura-2-AM
(Molecular probes, Eugene, OR) in normal Tyrode’s solu-
tion for 20 min at 37°C. After washing twice, the cells were
resuspended with normal Tyrode’s solution consisting of
10 mM HEPES, 145 mM NaCl, 3.6 mM KCl, 1 mM MgCl2,
1.3 mM CaCl2, and 5 mM glucose. Fluorescence emission at
510 nm was measured with excitation at 340/380 nm in a
stirred quartz-microcuvette (1 ml volume at 37°C) of fluo-
rescence spectrophotometer (Photon Technology Instru-
ment, Birmingham, NJ). Maximum and minimum fluores-
cence values at 380 nm (Fmax and Fmin) were calibrated with
0.2% Triton X-100 and 10 mM EGTA, respectively. The
[Ca2+]i was calculated from the equation, [Ca2+]=Kd ×β×
(R − Rmin)/( R max − R) where Kd is the dissociation constant
for Fura-2 (224 nM), β is Fmin/Fmax, and R is F340/F380.
Western blot analysis
The total proteins were prepared by incubation with RIPA
buffer containing protease inhibitor (Roche, Indianapolis, IN)
and phosphatase inhibitor cocktail (Calbiochem, Darmstadt,
Germany). The proteins were resolved in 8–12% SDS-
PAGE and analyzed with antibodies specific for caspase-3
(Cell Signaling, Danvers, MA), PARP (Cell Signaling), Bcl-
2 (SantaCruz, Santa Cruz, CA), p21 (SantaCruz), and p27
(SantaCruz). Antibody to GAPDH (SantaCruz) was used as
a loading control.
Statistical analysis
Data was expressed as mean ± SD. Statistical significance
was assessed by paired or unpaired t test using GraphPad
Prism. Differences resulting in p values <0.05 were consid-
ered to be statistically significant.
Results
Menthol increases antiproliferative activity of 1α,25(OH)2D3
To assess the antiproliferation activity of menthol, we
performed MTT assays using LNCaP cells. Cell growth was
gradually decreased depending on menthol concentration
(Fig. 1A). At high menthol concentrations above 1.6 mM,
the cells began to detach from the culture dish. Although
only a few cells were detached immediately after treatment
with menthol at 0.8 mM, overall cell growth was not
significantly reduced (Fig. 1A). The antiproliferative or
cytotoxic effect of menthol was evident only in the presence
of the supramillimolar concentration ranges, which indicates
that menthol per se has little antitumor activity. We then
investigated whether menthol can increase an antiprolifera-
tive activity of 1α,25(OH)2D3 in LNCaP cells. The combina-
tion of 1α,25(OH)2D3 with menthol above 0.8 mM sup-
pressed significantly cell growth, compared to 1α,25(OH)2D3
alone (Fig. 1B). Dose-response relationship study confirmed
that menthol markedly enhances an antiproliferative activity
of 1α,25(OH)2D3 (Fig. 1C). These results were further
corroborated by quantitating cell growth over time
(Fig. 1D). While 1α,25(OH)2D3 alone attenuated cell
growth, 1α,25(OH)2D3 combined with menthol almost
completely inhibited the growth. Under the conditions, the
considerable cell death, as examined by LDH release assay,
did not occur and little apparent morphological changes
were observed (data not shown).
Menthol, but not 1α,25(OH)2D3, evokes an increase in
[Ca2+]i
1α,25(OH)2D3 is known to increase [Ca2+]i through its
nongenomic action [4, 8]. Also, menthol can increase [Ca2+]i
via transmembrane influx or store release pathways [12, 13].
We thus examined whether 1α,25(OH)2D3 and/or menthol can
induce the change of [Ca2+]i in LNCaP cells. Fluorescence-
based ratiometric assays with Fura-2 showed that
1α,25(OH)2D3 does not increase [Ca2+]i in our assay condi-
tions (Fig. 2A), which indicates that no nongenomic Ca2+
response occurs in LNCaP cells. By contrast, mentholEffect of Menthol and Vitamin D on LNCaP Cell Growth
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Fig. 1. Antiproliferation effect of 1α,25(OH)2D3 and menthol in LNCaP cells. (A–C) Dose-response effect. The cells were cultured
with menthol alone (A), 1α,25(OH)2D3 at 10−4 mM plus menthol at the indicated concentrations (B), or menthol at 0.8 mM
plus 1α,25(OH)2D3 at the indicated concentrations (C) for 72 h prior to MTT assays. (D) Time-dependent effect. Cell growth is
expressed as a relative value to that of the untreated cells or that of cells harvested at zero time. NC, negative control (ethanol as
a vehicle); M, menthol; V, 1α,25(OH)2D3; M+V, menthol plus 1α,25(OH)2D3. The figures show mean ± SD (n = 3-6). *p<0.05,
**p<0.01, ***p<0.005.
Fig. 2. Intracellular Ca2+ change in LNCaP cells exposed to 1α,25(OH)2D3 and menthol. The [Ca2+]i was measured using Fura-2 as
described in Materials and Methods (A) The effect of 1α,25(OH)2D3 on [Ca2+]i. (B) The effect of menthol alone (0.8 mM) or
1α,25(OH)2D3 (10−4 mM) plus menthol (0.8 mM) on [Ca2+]i. Data shown are a representative result of at least three independent
experiments. Arrows indicates the point of treatments with 1α,25(OH)2D3 and/or menthol.E.-J. Park et al.
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elevated [Ca2+]i, as expected [11], which is comparable to the
[Ca2+]i increase by the combination of 1α,25(OH)2D3 with
menthol (Fig. 2B). Peak increase in [Ca2+]i was 102.3 ± 39
nM (n = 3) in menthol alone and 124.5 ± 51 nM (n =3 )  i n
combination of 1α,25(OH)2D3 with menthol, respectively.
Combination of 1α,25(OH)2D3 with menthol cooperatively
modulates bcl-2 and p21 expression
To get a clue to the molecular mechanisms underlying
the enhanced antiproliferation effect of the combination of
1α,25(OH)2D3 with menthol, we performed Western blot
analyses with LNCaP cells. Neither caspase-3 nor PARP,
a caspase-3 substrate, was cleaved in the experimental
conditions used (Fig. 3A) which indicates that 1α,25(OH)2D3
plus menthol does not induce caspase-3-dependent apoptosis.
We then examined the expression levels of an anti-apoptotic
gene bcl-2 and cell cycle inhibitors p21 and p27. The expres-
sion of bcl-2 was markedly reduced by the combined treat-
ment of 1α,25(OH)2D3 with menthol, which may permit the
cells to be vulnerable to apoptotic stimuli. The expression
level of bcl-2 appeared to be unaffected by either alone
(Fig. 3B). However, of five independent experiments, we
once observed the reduced expression of bcl-2 by
1α,25(OH)2D3 alone but not by menthol alone. The expres-
sion of p21 was reduced by treatment with either alone, but
the reduction of p21 was more remarkable when
1α,25(OH)2D3 was combined with menthol (Fig. 3B). The
expression of p27 was not affected by 1α,25(OH)2D3 or
menthol, either alone or in combination (Fig. 3B).
Discussion
In the present study we described the advantageous effect
of 1α,25(OH)2D3 combined with menthol. We showed that
menthol  per se exhibits little antiproliferative or pro-
apoptotic activity (Fig. 1A), but it is able to enhance an
antiproliferative activity of 1α,25(OH)2D3 in LNCaP cells
(Fig. 1B–D). These results suggest that menthol is helpful
to improve the anti-cancer efficacy and to reduce the
hypercalcemic toxicity of 1α,25(OH)2D3. In addition, our
findings suggest that menthol is a valuable probe to identify
the novel pathways that determine 1α,25(OH)2D3 reactivity.
1α,25(OH)2D3 is known to up-regulate the expression of
transient receptor potential vanilloid 6 (TRPV6), a Ca2+-
selective cation channel [14], TRPV6 mediates transcellular
Ca2+ transport at the apical membrane of the duodenal and
renal epithelial cells [15]. TRPV6 ablation mice showed
aberrant Ca2+ handling, such as reduced intestinal Ca2+
absorption and increased urinary Ca2+ excretion [15]. These
results suggest that TRPV6 is an crucial transcriptional
target of 1α,25(OH)2D3 for maintaining body Ca2+ home-
ostasis. In addition, 1α,25(OH)2D3 mediates Ca2+ influx via
membrane-type VDR and unidentified Ca2+ channel activa-
tion that is transcription-independent processes, which is
well exemplified in intestinal epithelial cells [4]. It has of
interest been shown that 1α,25(OH)2D3 increases the expres-
sion of TRPV6 in LNCaP cells. [14, 16]. Thus, it is likely
that 1α,25(OH)2D3 mediates Ca2+ transport via the genomic
action involving the transcriptional induction of TRPV6.
However, it has been undetermined whether 1α,25(OH)2D3-
mediated TRPV6 induction is a crucial mechanism for
1α,25(OH)2D3-induced growth inhibition. Little has been
known as to whether acute Ca2+ responses of 1α,25(OH)2D3
occurs in prostate cancer cells like those in intestinal
epithelial cells. In this study, we did not find that
1α,25(OH)2D3 elicits acute Ca2+ response in LNCaP cells
(Fig. 2A). When [Ca2+]i was measured for 30 min, we still
did not see acute [Ca2+]i increase (Data not shown). These
results suggest that membrane-type VDR or Ca2+ transport
proteins are impaired in LNCaP cells, permitting tumor cells
to be resistant to 1α,25(OH)2D3-induced growth inhibition,
which may be a survival strategy of tumor cells. In addition,
it is likely that the acute Ca2+ responsiveness to 1α,25(OH)2D3
is crucial for maximizing its therapeutic effect.
Menthol binds and activates transient receptor potential
melastatin 8 (TRPM8), a Ca2+-permeable nonselective
cation channel, to increase [Ca2+]i [ 12]. Compared to
1α,25(OH)2D3 (Fig. 2A), menthol evoked an increase in
[Ca2+]i in LNCaP cells (Fig. 2B). TRPM8 activation can be
sufficiently achieved by menthol at submillimolar concen-
trations [12, 13]. By contrast, our results showed that growth
inhibition or cell death occurs only in the presence of
supramillimolar concentrations of menthol (Fig. 1A), which
indicates that antiproliferative or cytotoxic activity of
menthol is independent of TRPM8 in LNCaP cells. However,
it is still unsolved question whether TRPM8 is a key mediator
in the enhanced cellular responses to 1α,25(OH)2D3 by
Fig. 3. The expression of apoptosis- or cell cycle-related genes
in LNCaP cells exposed to 10−4 mM 1α,25(OH)2D3 and
0.8 mM menthol. Western blot analyses of proteins
following treatment with 1α,25(OH)2D3 and menthol for
72 h. Data shown are a representative result of at least
four independent experiments. GAPDH was used as a
loading control.Effect of Menthol and Vitamin D on LNCaP Cell Growth
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menthol. Currently, answering this question is not easy due
to technical limitations, such as lack of TRPM8-specific
inhibitors. In addition, siRNA-mediated TRPM8 knock-
down may induce cell death; despite the underlying
molecular mechanisms are unclear [11]. Furthermore, a
recent study showed that menthol increases [Ca2+]i through
TRPM8-independent pathways [13]. Interestingly, both
TRPV6 and TRPM8 are up-regulated in the early-stage of
prostate cancer [17], which suggests that the simultaneous
or sequential activation of two different Ca2+ pathways
contributes to growth inhibition of prostate cancer. How-
ever, a causal relationship between these channels and
tumorigenesis or tumor progression is uncertain. Moreover,
little is known about the regulatory mechanisms of both
channels concerning pathophysiologically relevant condi-
tions, such as proliferative inflammatory atrophy [18].
The effect of 1α,25(OH)2D3 on the expression level of
bcl-2 or p21 is controversial, probably due to the cell-types
and experimental conditions used [4, 19]. In this study, we
found that the expression level of bcl-2 was reduced only by
the combination of 1α,25(OH)2D3 with menthol (Fig. 3B).
In addition, we showed that combined treatment more
remarkably reduces the expression level of p21 than treat-
ment with either 1α,25(OH)2D3 or menthol alone. Previous
preclinical studies showed that the reduction of p21 sensitizes
cancer cells to anticancer drugs [19]. Thus, these results
raise the possibility that 1α,25(OH)2D3 plus menthol can
sensitize the cancer cells to chemotherapeutic agents.
Unfortunately, here we did provide the detailed molecular
mechanisms by which menthol enhances 1α,25(OH)2D3
activity. Our preliminary results from reporter assays
showed that menthol does not activate 1α,25(OH)2D3-
mediated transcription (data not shown), which suggests that
the effect of menthol is unrelated to the modulation of VDR
activity. In several cancers, 24-hydroxylase, a 1α,25(OH)2D3
catabolic enzyme, is known to be up-regulated to inactivate
1α,25(OH)2D3 rapidly [4], which may be a tumor escaping
mechanism conferring vitamin D resistance. Thus, the effect
of menthol on 1α,25(OH)2D3 metabolic enzymes appears to
be a challengeable issue to be determined.
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